Table 2.

Relative survival percent, 95% confidence intervals and survival difference between year 1 and 5 for multiple myeloma patients aged 0–89 years in Sweden 1 and 5 years after diagnosis.

Myeloma survival (%)
Period		1-year	5-year		1–5 years%a
Men
1967–1971	54	[51; 57]*	24	[21; 27]	30
1972–1976	65	[62; 68]	26	[23; 29]	39
1977–1981	67	[64; 70]	31	[28; 34]	36
1982–1986	72	[69; 74]	31	[28; 34]	41
1987–1991	74	[72; 77]	33	[31; 36]	41
1992–1996	77	[75; 79]	34	[32; 37]	43
1997–2001	78	[75; 80]	36	[34; 39]	42
2002–2006	80	[78; 82]*	41	[38; 43]*	39
2007–2011	86	[85; 88]	51	[48; 54]	35
2012–2016	88	[87; 90]	54	[52; 56]	34
Women
1967–1971	64	[61; 67]	25	[22; 28]	39
1972–1976	67	[64; 70]	29	[26; 33]	38
1977–1981	71	[68; 74]	29	[26; 33]	42
1982–1986	72	[70; 75]	33	[30; 37]	39
1987–1991	77	[74; 79]	35	[32; 38]	42
1992–1996	80	[77; 82]	37	[34; 41]	43
1997–2001	83	[81; 85]	39	[37; 43]	44
2002–2006	83	[81; 85]	45	[42; 48]	38
2007–2011	85	[83; 87]	48	[46; 51]	37
2012–2016	88	[86; 90]	53	[50; 55]	35

^a 1–5 years% is the difference between survival percentages between year 1 and 5.

*Indicates that the 95%CIs between periodic survival percentages do not overlap (compared to the period below).